| | | | | When Californian counties and cities first sued paint makers in 2000, they wanted the companies to pay billions to remove dangerous old lead paint from hundreds of thousands of homes. | | |
| | | After a 19-year legal struggle, three former makers of lead paint have agreed to a $305 million settlement with California county and city governments to mitigate poisoning dangers still present in old housing. | | |
| | | U.S. stock indexes dipped on Wednesday as weak results from CSX Corp stoked concerns that the protracted trade war between the United States and China could hurt corporate earnings. | | |
| | | Oil futures fell more than 1% on Wednesday, extending a more than 3% drop in prices the previous session, after U.S. government data showed large builds in refined product stockpiles. | | |
| | | U.S. lawmakers bashed Facebook on Wednesday over its planned cryptocurrency, after a bruising first bout a day earlier when senators from both parties condemned the project, saying the company had not shown it could be trusted. | | |
| | | Amazon's use of merchants' data triggered an EU antitrust investigation on Wednesday, as regulatory concerns mount around the world on how tech giants exploit customer information to reinforce their market power. | | |
| | | A gauge of global stocks declined for a second straight session and U.S. Treasury yields fell as trade concerns began to percolate and the pace of the U.S. corporate earnings season picked up. | | |
| | | Boeing Co said on Wednesday it will dedicate half of a $100 million fund it created after two crashes of its 737 MAX planes to provide payments to families of those killed, with compensation expert Ken Feinberg hired by the world's largest plane maker to oversee the distribution. | | |
| | | The Qatari-backed lawyer tasked with trying to draw a line under Deutsche Bank's regulatory scandals has risen rapidly at the German bank, jumping to the management board after three years as a "sparring partner" on the bank's supervisory body. | | |
| | | Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the $59 billion purchase of Shire, sources close to the matter told Reuters. | | |
|
| |
